MedTrace Logo

A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm

NCT05593393 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2022-11-14

No results posted yet for this study

Summary

Study objective: To establish a long-term follow-up cohort of patients with IPMN, study the follow-up, clinical outcomes and prognostic factors of patients with IPMN, and provide a basis for clinical decisions and guidelines.

Study design: This is a real world, multicenter, prospective, observational cohort study

Conditions

  • IPMN, Pancreatic

Interventions

DEVICE

Endoscopic ultrasound

The EUS follow-up will be conducted at baseline and every 12 months thereafter. For patients with new WF or HRS in the evaluation, the follow-up physician and the patient can jointly decide whether to perform EUS evaluation in the 6 or 3 month intensive follow-up.

Sponsors & Collaborators

  • Beijing Hospital

    collaborator OTHER_GOV

  • Tongji Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Xiamen University

    collaborator OTHER

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Xi Wu, M.D. · Peking Union Medical College Hospital

  • Shengyu Zhang, M.D. · Peking Union Medical College Hospital

  • Yiran Su, MD candidate · Peking Union Medical College Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2025-09-30
Completion
2025-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05593393 on ClinicalTrials.gov